Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 14:4:2050312116654404.
doi: 10.1177/2050312116654404. eCollection 2016.

Delivering a one-stop, integrated, and patient-centered service for patients with rheumatic diseases

Affiliations

Delivering a one-stop, integrated, and patient-centered service for patients with rheumatic diseases

Paula Väre et al. SAGE Open Med. .

Abstract

Objective: To describe a one-stop, integrated rheumatology service and assess patient satisfaction.

Methods: A descriptive report and patient satisfaction survey of a rheumatology clinic model first developed in 1996 to enhance the patient "journey" through rheumatology services. A patient-satisfaction survey over a 3-week period assessed several aspects of care including quality of services, consultations, and patient education.

Results: All referrals are screened by a rheumatologist to pre-schedule laboratory/radiology/other tests for the visit. Upon arrival to the clinic, patients check-in at an electronic desk, and then complete the electronic GoTreatIT monitoring system which assesses patient-reported outcomes. The patient is reviewed by a doctor in a 30- to 60-min consultation, and then by a nurse (for diagnosis/treatment education, vaccinations). An ultrasound machine and capillaroscopy are available for use in the clinic. Patients can be scheduled on the same day to see a nutritionist, physiotherapist, or other heath professionals as necessary. An "early-rheumatoid arthritis treatment path" is available to ensure early, intensive treatment. A patient satisfaction survey revealed high rating of the overall service (90.6/100). None of the patients felt that they lacked education on their disease or medication. Only 6% of the respondents gave negative feedback, reasons including feeling overwhelmed with information or not being given a cause for their symptoms. The multi-disciplinary approach was highly valued and only 3% would rather see a doctor and nurse on separate days.

Conclusion: The specific clinic model provides an ideal setting for a one-stop service, avoiding unnecessary visits, collecting patient data, and enhancing the patient experience and journey through the system. Where possible, the specific clinic model could be used or adapted to build similar models in other rheumatology departments. The clinic model could also form the basis for services in other specialties dealing with chronic conditions.

Keywords: Clinic model; integrated service; patient satisfaction; rheumatology.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Paula Väre received speaking fee MSD. Elena Nikiphorou reports no financial disclosures. Pekka Hannonen received consultation fees from Abbvie, MSD, Pfizer, Roche, and Mundipharma; travel grants from BMS, MSD, Pfizer, and Roche; and speaking fees from Abbivie, Astra-Zeneca, BMS, MSD, Pfizer, Roche, Professio Finland. Tuulikki Sokka received honoraria, consultation fees, support for travel, research grants from Abbott, Abbvie, BMS, DiaGraphIT, Eli Lilly, GSK, Hospira, Medac, MSD, Muikkusäätiö, Novo Nordisk, Orion Pharma, Pfizer, Roche, UCB, and Academy of Finland.

Figures

Figure 1.
Figure 1.
Extract from GoTreatIT demonstrating an example of electronic recording for tender and swollen joint counts.
Figure 2.
Figure 2.
Treatment pathway for newly-diagnosed rheumatoid arthritis patients in the Jyvaskyla rheumatology clinic model.

Similar articles

Cited by

References

    1. Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014; 73: 492–509. - PMC - PubMed
    1. Allaart CF, Breedveld FC, Dijkmans BA. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study. J Rheumatol Suppl 2007; 80: 25–33. - PubMed
    1. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364(9430): 263–269. - PubMed
    1. Sokka T, Mäkinen H, Puolakka K, et al. Remission as the treatment goal—the FIN-RACo trial. Clin Exp Rheumatol 2006; 24(6 Suppl. 43): S-74–S-76. - PubMed
    1. Kauppi MJ, Säilä H, Belt EA, et al. Beware of the biologicals—hospitals may die: the Rheumatism Foundation Hospital, Heinola, Finland (1951–2010). Clin Rheumatol 2012; 31(8): 1151–1154. - PubMed

LinkOut - more resources